Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Levodopa and Carbidopa (Gastroenteral use)

EU orphan designation number: EU/3/01/035   
Active ingredient: Levodopa and Carbidopa (Gastroenteral use)
Indication: Treatment of advanced idiopathic Parkinsonīs disease with severe motor fluctuations and not responding to oral treatment
Sponsor: AbbVie Ltd
Maidenhead, SL6 4XE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/05/2001 Centralised Orphan - Designation EMEA/OD/052/00 (2001)1197 of 10/05/2001
16/03/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/052/00/T/01 (2006)727 of 02/03/2006
21/01/2011 Other procedure
08/02/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/052/00/T/02 (2013)731 of 06/02/2013